Randomized Phase III Trial Evaluating the Impact of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer
Interventional
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Relapse free survival
There is a follow-up period of 3 years.
from randomization to relapse or last contact (up to 3 years)
Yes
Philippe MORICE, Pr
Principal Investigator
Gustave Roussy, Cancer Campus, Grand Paris
France: Committee for the Protection of Personnes
GYNECO 02/0108
NCT01363466
May 2003
November 2006
Name | Location |
---|